The Aaron's Company, Inc. AAN
10.09 0.00 (+0.00%)
At closeOct 3, 2024, 4:02 PM EDT
10.08 Day range 10.10
52-week range unavailable
- Market cap
- 318.35M
- Revenue (ttm)
- 2.07B
- Profit margin
- -2.06%
- Shares out
- 31.55M
- Forward P/E
- 24.02
- Dividend
- 0.50 (4.96%)
- Ex-dividend date
- Sep 12, 2024
- Volume
- 2.78M
- Open
- 10.08
- Previous close
- 10.09
- Day's range
- 10.08 – 10.10
- Beta
- 1.42
- Analysts
- Hold
- Price target
- 10.07 (-0.2%)
- Earnings date
- Oct 28, 2024
2Y -0.25 (-2.42%)
Key statistics
- Enterprise value
- 976.87M
- PEG ratio
- -3.86
- Price / sales
- 0.15
- Price / book
- 0.47
- Dividend yield
- 4.96%
- Payout ratio
- 555.56%
- Revenue growth
- -5.10%
- Free cash flow
- 500.72M
- Total cash
- 34.16M
- Total debt
- 701.14M
- Return on equity
- -6.22%
- Short % of float
- 15.28%
- 50-day average
- 10.04
- 200-day average
- 9.11
Analyst view
Consensus: hold
Hold
Price target (mean) 10.07 -0.2% downside
Now 10.09
- Target (low)
- 10.00
- Target (mean)
- 10.07
- Target (high)
- 10.10
Ratings (0m) 11 7 buy · 4 hold · 0 sell
- Strong buy5
- Buy2
- Hold4
- Sell0
- Strong sell0
Next earnings
Oct 28, 2024
Expected Oct 28, 2024. Consensus EPS estimate 0.11.
Financials — quick view
AAN Revenue — quarterly 503.13M
AAN Net income — quarterly -11.90M
AAN EPS — quarterly -0.39
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 28, 2024 | Sep 1, 2024 | 0.10 | — | — | — |
| Aug 5, 2024 | Jun 1, 2024 | 0.03 | — | — | — |
| May 6, 2024 | Mar 1, 2024 | -0.08 | — | — | — |
| Feb 26, 2024 | Dec 1, 2023 | 0.03 | — | — | — |
| Oct 23, 2023 | Sep 1, 2023 | 0.06 | — | — | — |
| Jul 31, 2023 | Jun 1, 2023 | 0.18 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 9, 2023 | Jefferies | main | Buy | Buy |
| Oct 4, 2023 | Truist Securities | main | Hold | Hold |
| Aug 1, 2023 | Truist Securities | main | Hold | Hold |
| Jul 31, 2023 | Stephens & Co. | reit | Equal-Weight | Equal-Weight |
| Jul 10, 2023 | Jefferies | main | Buy | Buy |
| Jul 9, 2023 | Loop Capital | down | Buy | Hold |
About The Aaron's Company, Inc.
The Aaron's Company, Inc. provides lease-to-own and retail purchase solutions. It operates through Aaron's Business and BrandsMart segments. The company engages in direct-to-consumer sales and lease solution of furniture, appliances, electronics, computers, and other home products through company-operated and franchised stores in the United States and Canada, as well as its e-commerce platforms, including aarons.com and brandsmartusa.com. It also manufactures and supplies upholstered furniture. The company sells its products under the Aaron's, BrandsMart U.S.A., BrandsMart Leasing, and Woodhaven Furniture Industries brands. The company was formerly known as Aaron's SpinCo, Inc. The Aaron's Company, Inc. was founded in 1955 and is based in Atlanta, Georgia. As of October 3, 2024, The Aaron's Company, Inc. was taken private.
- Sector
- Industrials
- Industry
- Rental & Leasing Services
- Country
- United States
- Website
- aarons.com
News
Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting 
Ionis presents new data from pivotal study of zilganersen in Alexander disease (AxD) at AAN 2026 Annual Meeting 
Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks 
Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting 
argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP 
Acadia Pharmaceuticals to Present Data at the 2026 American Academy of Neurology (AAN) Annual Meeting 
Lexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting 
Alkermes to Present Additional Data From Vibrance-1 Phase 2 Study of Alixorexton in Patients with Narcolepsy Type 1 at the American Academy of Neurology (AAN) 2026 Annual Meeting 
Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026 
Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting
Your note
Sign in to keep a note on AAN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BACDAYAN WANGDALI C. | Director | Stock Award(Grant) | May 14, 2024 | 50,679 |
| BAILEY LAURA N | Director | Stock Award(Grant) | May 14, 2024 | 42,041 |
| BARRETT KELLY HEFNER | Director | Stock Award(Grant) | May 14, 2024 | 47,126 |
| EHMER WALTER G | Director | Stock Award(Grant) | May 14, 2024 | 46,974 |
| GEORGE RACHEL G | General Counsel | Purchase | Jul 7, 2024 | 78,884 |
| HARRIS HUBERT L JR | Director | Stock Award(Grant) | May 14, 2024 | 53,196 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 19.29% | 5,955,388 | 84.21M | Jun 29, 2023 |
| Vanguard Group Inc | 7.52% | 2,321,751 | 32.83M | Jun 29, 2023 |
| Dimensional Fund Advisors LP | 5.65% | 1,743,950 | 24.66M | Jun 29, 2023 |
| Palisade Capital Management, L.P. | 4.05% | 1,249,095 | 17.66M | Jun 29, 2023 |
| State Street Corporation | 3.87% | 1,195,072 | 16.90M | Jun 29, 2023 |
| Lsv Asset Management | 3.11% | 958,932 | 13.56M | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.76% | 853,131 | 12.06M | Jun 29, 2023 |
| Pacer Small Cap U.S. Cash Cows 100 ETF | 2.49% | 768,864 | 12.16M | Jul 30, 2023 |
| iShares Russell 2000 ETF | 2.35% | 724,234 | 8.74M | Aug 30, 2023 |
| DFA U.S. Small Cap Value Series | 1.51% | 464,928 | 7.36M | Jul 30, 2023 |
| Vanguard Extended Market Index Fund | 1.49% | 460,233 | 6.51M | Jun 29, 2023 |
| Schwab Strategic Tr-Schwab Fundamental U.S. Small Company Index ETF | 1.45% | 446,672 | 5.47M | May 30, 2023 |